Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Gestational diabetes | Image credit: Phushutter - stock.adobe.com

Questionnaire Evaluates Obstetric Nurse Competency in Managing Gestational Diabetes

By Pearl Steinzor

May 8th 2025

A validated questionnaire assesses skills, knowledge, and attitudes for effective gestational diabetes management.

Diabetes monitoring | Image credit: abidika - stock.adobe.com

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

By Pearl Steinzor

April 23rd 2025

Rural health sign | Image credit: BJP7images - stock.adobe.com

FQHCs Show Low Engagement in Hypertension, Diabetes Trials

By Pearl Steinzor

April 15th 2025

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com

Housing Instability Linked to Worse Type 2 Diabetes Outcomes

By Pearl Steinzor

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com

GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

By Pearl Steinzor

April 9th 2025

More News

December 21st 2018

This Week in Managed Care: December 21, 2018

This week, the top managed care news included a federal judge ruling that the Affordable Care Act is unconstitutional; new diabetes standards address cardiovascular risk; efforts targeting loneliness show improved health outcomes.

December 21st 2018

5 Things to Know About the ADA 2019 Standards of Care

Mary Caffrey

The relationship between diabetes management and preventing cardiovascular events was a theme throughout 2018, and this is reflected in the new standards.

December 20th 2018

Diabetes, Cancer Interviews Among Most-Watched Videos of 2018

Laura Joszt, MA

Throughout the year, The American Journal of Managed Care® (AJMC®) offered a number of video programs, including Peer Exchange discussions and interviews, on a range of topics. Here are the most-watched videos published by AJMC® in 2018.

December 18th 2018

ADA Embraces CV Risk Calculator, Calls for Using GLP-1s Before Insulin in Type 2 Diabetes

Mary Caffrey

The 2019 Standards of Care reflect an ongoing collaboration between the American Diabetes Association and the American College of Cardiology.

December 17th 2018

The Most-Read News Stories of 2018

Allison Inserro

Two of The American Journal of Managed Care®'s top 5 most-read news stories were themselves top-5 roundups of hot topics in healthcare this year. The list was rounded out by cardiovascular, diabetes, and cancer news.

December 13th 2018

Diabetic Amputations May Be Rising in the United States

Mary Caffrey

The report in Diabetes Care, the official journal of the American Diabetes Association, comes after reports of rising rates of diabetes and obesity among young adults and soaring insulin costs, which may mean diabetes is not being effectively treated.

December 9th 2018

Podcast: This Week in Managed Care—US Life Expectancy Declines and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

December 7th 2018

This Week in Managed Care: December 7, 2018

This week, the top managed care news included a CDC report that found life expectancy in the United States declined again; telemedicine use among physicians remains low; another study added to the debate over who should take statins.

December 7th 2018

AJMC® in the Press, December 7, 2018

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

December 5th 2018

Alcohol May Keep Patients With Diabetes From Reaching Long-Term Weight Loss Goals

Kelly Davio

A newly published study from the University of Pennsylvania School of Nursing finds that heavy alcohol consumption poses a risk for suboptimal long-term weight loss among patients with a diagnosis of type 2 diabetes.

December 5th 2018

Mental Health and Diabetes Control Among Vulnerable Primary Care Patients

Darrell L. Hudson, PhD, MPH Melvin S. Blanchard, MD Cassandra Arroyo-Johnson, PhD, MS Laurel Milam, MA Kimberly A. Kaphingst, ScD Melody S. Goodman, PhD, MS

Only 19% of patients in this sample had good diabetes control based on their tested glycated hemoglobin levels. Patients diagnosed with mental health conditions in this study were more likely to have good diabetes control.

November 30th 2018

CDC Data: Life Expectancy Decreases as Deaths From Suicide, Drug Overdose Increase

Laura Joszt, MA

New reports from the CDC have highlighted troubling increasing trends in suicides and drug overdose rates as life expectancy in the United States declined.

November 30th 2018

This Week in Managed Care: November 30, 2018

This week, the top managed care news included a CMS plan for changes in drug coverage that brought a wave of criticism; a government task force recommended more people at risk for HIV take pre-exposure prophylaxis, known as PrEP; the American College of Cardiology issued an Expert Consensus Pathway on treatment of patients with type 2 diabetes and atherosclerotic cardiovascular disease.

November 29th 2018

Increasing Awareness This National Diabetes Month Can Save Limbs and Lives

Foluso A. Fakorede, MD

Atherosclerosis and peripheral artery disease are significant long-term complications of diabetes that demand more education and quality care to prevent limb loss. The conclusion of National Diabetes Month offers an opportunity to draw attention to ways to prevent these outcomes and screen for them early.

November 29th 2018

ACC Pathway Finds Empagliflozin "Preferred" SGLT2 Therapy for Patients With Type 2 Diabetes, ASCVD

Mary Caffrey

The authors noted that until recently, medications to control blood glucose were not expected to offer any benefit in helping patients avoid cardiovascular events.

November 11th 2018

Cardiovascular Results for Dapagliflozin Point to SGLT2 Use to Prevent Heart Failure

Mary Caffrey

Results presented at the American Heart Association in Chicago provided the strongest evidence to date on what heart failure specialists have discussed for several years now: the possibility that SGLT2 inhibitors might be used to prevent heart failure in patients with type 2 diabetes.

November 5th 2018

What We're Reading: Biosimilar Rituximab; Turning Back Time on EHRs; OTC Cough Products for Kids

AJMC Staff

Sandoz announced it will no longer pursue FDA approval for its proposed biosimilar rituximab; when it comes time to set the clocks back an hour for daylight saving time, hospitals opt for paper records during the night shift to compensate for challenges with electronic health records; new research on the effectiveness of over-the-counter (OTC) medicines finds little evidence that these products will relieve a child’s symptoms when sick.

November 3rd 2018

Podcast: This Week in Managed Care—International Pricing Index for Medicare and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

November 2nd 2018

Congress' Diabetes Caucus Seeks Transparency, Value-Based Contracts to Control Insulin Prices

Mary Caffrey

The report, more than a year in the making, comes at the start of Diabetes Awareness Month.

November 2nd 2018

This Week in Managed Care: November 2, 2018

This week, the top managed care news included a proposal to allow Medicare to pay the same prices for certain drugs as what other countries pay; President Donald Trump signed a law to fight the opioid crisis; an FDA advisory panel voted narrowly to retain a 10-year-old guidance for safety trials for diabetes drugs.

October 31st 2018

AJMC® Research Roundup: October 2018

Here are 5 interesting findings from the October 2018 issue of AJMC®.

October 29th 2018

Narrow Vote Calls for Keeping Drug Safety Trials, but Many See Changes

Mary Caffrey

Cardiovascular outcomes trials have changed type 2 diabetes drug development and added to the knowledge base, but some think these giant studies make therapies too costly and discourage innovation.

October 25th 2018

Amgen Announces 60% Reduction in List Price of PCSK9 Inhibitor Evolocumab

Surabhi Dangi-Garimella, PhD

Amgen has announced that the price of its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, evolocumab (Repatha), will be reduced by 60%, from an annual price of $14,100 down to $5850.

October 19th 2018

5 Findings From the October 2018 Issue of AJMC®

Christina Mattina

The October 2018 issue of The American Journal of Managed Care® (AJMC®) includes studies on diabetes outcomes, the effect of feedback reports on physician behavior, accountable care organization performance, and more. Here are 5 findings from the research published in the issue.

October 17th 2018

Communication Patterns in EHRs Have Surprising Impact on Outcomes for Patients With Diabetes, AJMC® Researchers Say

Casting messages widely throughout an electronic health record instead of using more focused direct messaging in diabetes care leads to more hospital visits and higher medical costs, according to a study published in the current issue of The American Journal of Managed Care®.

October 13th 2018

Analysis Estimates Empagliflozin Will Add Years to Life for People With Type 2 Diabetes

Mary Caffrey

The analysis of data from EMPA-REG OUTCOME arrives as the FDA weighs the future of these large trials.

October 9th 2018

Nudging Physicians and Patients With Autopend Clinical Decision Support to Improve Diabetes Management

Laura Panattoni, PhD Albert Chan, MD, MS Yan Yang, PhD Cliff Olson, MBA Ming Tai-Seale, PhD, MPH

Incorporating an autopend functionality into clinical decision support improved glycated hemoglobin laboratory test completion by between 21.1% and 33.9% for reminder messages read within 57 days.

October 9th 2018

Joint Statement Released on Managing Hyperglycemia in Type 2 Diabetes

Mary Caffrey

Patient preference should be considered because medications don't work if adherence is poor, the experts noted.

October 8th 2018

Medicare Underpayment for Diabetes Prevention Program: Implications for DPP Suppliers

Amanda S. Parsons, MD Varna Raman, MBA Bronwyn Starr, MPH Mark Zezza, PhD Colin D. Rehm, PhD

The actual costs of implementing the evidence-based Diabetes Prevention Program (DPP) were compared with the latest reimbursement rates provided by CMS.

October 5th 2018

Putting the Pieces Together: EHR Communication and Diabetes Patient Outcomes

Marlon P. Mundt, PhD Larissa I. Zakletskaia, MA

More frequent electronic health record (EHR) message forwarding in primary care teams is associated with worse outcomes and higher medical costs for patients with diabetes.

...

22 23 24 25 26 27 28 29 30

...

98 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions